CURRENT CSTL MEMBERS
David Baltimore (2016)
President Emeritus and Robert Andrews Millikan Professor of Biology
California Institute of Technology
David S.Tatel (2016)
U.S. Court of Appeals for the District of Columbia Circuit
Barbara E. Bierer (2013)
Professor of Medicine
Harvard Medical School
Senior Vice President, Research
Brigham and Women’s Hospital
Elizabeth H. Blackburn (2013)
Morris Herzstein Professor of Biology and Physiology
University of California, San Francisco
John Burris (2013)
Burroughs Wellcome Fund
Claude Canizares (2014)
Vice President and Bruno Rossi Professor of Physics
Massachusetts Institute of Technology
Arturo Casadevall (2013)
Leo and Julia Forchheimer Professor of Microbiology and
Immunology; Chair, Department of Biology and Immunology; and
Professor of Medicine
Albert Einstein College of Medicine
Joe S. Cecil (2015)
Project Director, Program on Scientific and Technical Evidence
Division of Research
Federal Judicial Center
Rochelle C. Dreyfuss (2013)
Pauline Newman Professor of Law and Director
Engelberg Center on Innovation Law and Policy
New York University School of Law
Harry T. Edwards (2015)
U.S. Court of Appeals for the District of Columbia Circuit
Drew Endy (2013)
Assistant Professor, Bioengineering
The BioBricks Foundation
Marcus Feldman (2013)
Burnet C. and Mildred Wohlford Professor of Biological Sciences
Jeremy Fogel (2014)
The Federal Judicial Center
Alice P. Gast (2013)
Benjamin W. Heineman, Jr. (2013)
Harvard Law School and Harvard John F. Kennedy School of
D. Brock Hornby (2013)
U.S. District Court, District of Maine
Alan B. Morrison (2013)
Associate Dean for Public Interest and Public Policy
George Washington University Law School
Cherry Murray (2014)
Dean and John A. and Elizabeth S. Armstrong Professor of
Engineering and Applied Sciences
Harvard School of Engineering and Applied Sciences
Roberta Ness (2014)
Dean and M. David Low Chair in Public Health
The University of Texas School of Public Health
Harriet Rabb (2013)
Vice President and General Counsel
David Relman (2014)
Thomas C. and Joan M. Merigan Professor, Departments of Medicine,
and of Microbiology and Immunology, Stanford University; Chief,
Infectious Disease Section, VA Palo Alto Health Care System
Richard Revesz (2014)
Lawrence King Professor of Law; Dean Emeritus; and Director, Institute for Policy Integrity
New York University School of Law
Anne-Marie Mazza, Director
Steven Kendall, Program Officer
CSTL CO-CHAIRS EMERITI
Donald Kennedy (1/1/2000-11/30/2009)
President Emeritus and Bing Professor of Environmental Science Emeritus
David Korn (12/1/2009 -- 12/31/2013)
Consultant in Pathology
Massachusetts General Hospital
Professor of Pathology
Harvard Medical School
Richard A. Merrill (1/1/2000-11/30/2009)
Daniel Caplin Professor of Law Emeritus
University of Virginia Law School
Richard A. Meserve (12/1/2009 -- 12/31/2013)
Carnegie Institution for Science
Senior Of Counsel
Covington & Burling LLP
FORMER CSTL MEMBERS
Shirley Abrahamson (7/1/2003-11/30/2007)
Wisconsin Supreme Court
Frederick R. Anderson, Jr. (1/1/2000-11/30/2011)
McKenna Long & Aldridge LLP
Margaret Berger (1/1/2000-11/30/2008)
Professor of Law
Brooklyn Law School
Arthur I. Bienenstock (7/1/2003-11/30/2011)
Special Assistant to the President for Federal Research Policy and Director, Wallenberg Research Link
Sherwood Boehlert (1/27/2012-10/11/2012)
U.S. House of Representatives
Paul D. Carrington (1/1/2000-6/30/2006)
Professor of Law
Richard F. Celeste (12/1/2006-11/30/2009)
Joel E. Cohen (1/1/2000-11/30/2009)
Abby Rockefeller Mauzé Professor and Head, Laboratory of Populations
The Rockefeller University and Columbia University
Kenneth M. Dam (7/1/2003-11/30/2008)
Max Pam Professor Emeritus of American and
Foreign Law and Senior Lecturer
School of Law
The University of Chicago
Rebecca S. Eisenberg (1/1/2000-6/30/2006)
Robert and Barbara Luciano Professor of Law
University of Michigan
Paul Falkowski (1/1/2009-11/30/2011)
Board of Governors Professor in Geological and Marine Science
Department of Earth and Planetary Science
Rutgers, The State University of New Jersey
David J. Galas (8/4/2003-6/30/2006)
Chief Scientific Officer
Battelle Memorial Institute
David L. Goodstein (1/1/2000-6/30/2006)
Professor of Physics and Applied Physics
California Institute of Technology
Lawrence O. Gostin (12/1/2006-11/30/2009)
Associate Dean for Research and Academic Programs, Linda D. and Timothy J. O’Neill Professor of Global Health Law, and Faculty Director, O’Neill Institute for National and Global Health Law, Georgetown University; Professor of Public Health, Johns Hopkins University; Director of the Center for Law & the Public’s Health, Johns Hopkins and Georgetown Universities
Jason Grumet (2/11/2010-11/30/2012)
Bipartisan Policy Center
Gary Hart (1/8/2008-11/30/2010)
Wirth Chair in Environmental and Community Development
University of Colorado
Barbara S. Hulka (1/1/2000-3/5/2003)
Professor of Epidemiology
University of North Carolina at Chapel Hill
Sheila Jasanoff (4/4/2000-11/30/2007)
Pforzheimer Professor of Science and Technology Studies
John F. Kennedy School of Government, Harvard University
Robert E. Kahn (1/1/2000-6/30/2003)
Chairman, CEO, and President
Corporation for National Research Initiatives
Daniel J. Kevles (1/1/2000-6/30/2006)
Stanley Woodward Professor of Histor and Professor (Adjunct) of Law
Eric S. Lander (1/1/2000-6/30/2003)
The Broad Institute
Wallace Loh (1/27/2012-10/21/2013)
University of Maryland, College Park
Robert A. Lonergan (7/1/2003-11/30/2007)
Vice President and General Counsel
Rohm and Haas Company
Patrick A. Malone (1/1/2000-6/30/2006)
Patrick Malone & Associates, PC
Margaret Marshall (1/27/12-9/16/2013)
Chief Justice (retired)
Massachusetts Supreme Judicial Court
Duncan T. Moore (12/1/2006-11/30/2009)
The Institute of Optics
University of Rochester
Harry Pearce (1/1/2000-6/30/2003)
Bowman and Brooke LLP
Henry Petroski (1/1/2000-6/30/2003)
Aleksandar S. Vesic Professor of Civil Engineering and Professor of History
Prabhu Pingali (2/11/2010-11/30/2012)
Deputy Director of Agricultural Development
Global Development Program
Bill & Melinda Gates Foundation
Thomas D. Pollard (7/1/2003-6/30/2006)
Eugene Higgins Professor of Molecular, Cellular & Developmental Biology, and Cell Biology and Chair, Molecular, Cellular & Developmental Biology
Paul D. Rheingold (12/1/2006-11/30/2009)
Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP
Channing R. Robertson (1/1/2000-6/30/2006)
Ruth G. and William K. Bowes Professor and
Dean of Faculty and Academy Affairs
Department of Chemical Engineering
Barbara Jacobs Rothstein (12/1/2006-2/1/2012)
Senior District Judge
Western District of Washington
Pamela Ann Rymer (1/1/2000-6/30/2003)
U. S. Court of Appeals for the Ninth Circuit
Jonathan M. Samet (7/1/2003-11/30/2010)
Professor and Flora L. Thornton Chair
Department of Preventative Medicine
Keck School of Medicine
Director, Institute for Global Health
University of Southern California
Fern M. Smith (7/1/2003-6/30/2006)
Retired U.S. District Judge
U.S. District Court for the Northern District of California
James Gustave Speth (7/1/2003-8/31/2005)
Carl W. Knobloch, Jr. Dean of the School of Forestry and Environmental Studies and Sara Shallenberger Brown Professor in the Practice of Environmental Policy
Sophie Vandebroek (2/11/2010-11/30/2012)
Chief Technology Officer and President
Xerox Innovation Group
Sheila Widnall (7/1/2003-11/30/2007)
Massachusetts Institute of Technology
CSTL MEMBER BIOGRAPHIES
David Baltimore (NAS/IOM), former president of the California Institute of Technology (1997-2006), is President Emeritus and the Robert Andrews Millikan Professor of Biology and is one of the world's most influential biologists. He has contributed widely to the understanding of cancer, AIDS and the molecular basis of the human body's immune response and has profoundly influenced national science policy on such issues as the AIDS epidemic and research in genetic engineering. In 1975 he was awarded the Nobel Prize in Physiology or Medicine for his research into viral replication that provided the key to understanding the life cycle of retroviruses. His present research focuses on control of inflammatory and immune responses as well as on the use of gene therapy methods to treat HIV and cancer in a program called “Engineering Immunity”. In addition, he co-directs the Joint Center for Translational Medicine, an activity that joins Caltech and UCLA in a program to translate basic science discoveries into clinical realities.
Dr. Baltimore has played an important role in the development of American biotechnology since his involvement in the 1970’s in the formation of Collaborative Genetics. He helped found other companies, most recently Calimmune and Immune Design and presently serves on the Board of Directors at several companies and non-profits including the Broad Foundation and the Broad institute, and Amgen and Regulus Therapeutics. He is a scientific advisor to the Ragon Institute and the biotech company Pacific Biosciences. He is a Science Partner to the venture capital firm The Column Group and until recently, was a Director of the Swiss investment company BB Biotech. He is past-Chair of the American Association of the Advancement of Science and was most recently named Riken Honorary Fellow. He is the 1999 recipient of the National Medal of Science and he has published more than 650 peer-reviewed articles.
Barbara E. Bierer, M.D. is Senior Vice President for Research at the Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. Dr. Bierer, a graduate of Harvard Medical School, completed her internal medicine residency at the Massachusetts General Hospital and her hematology and medical oncology training at the Brigham and Women’s Hospital and the Dana-Farber Cancer Institute. Dr. Bierer maintained a research laboratory in the Department of Pediatric Oncology at Dana-Farber Cancer Institute and was appointed Director of Pediatric Stem Cell Transplantation at Dana-Farber Cancer Institute and Children’s Hospital in 1993. In 1997, she was named Chief of the Laboratory of Lymphocyte Biology at the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD. She served on the Scholars Committee of the Howard Hughes Medical Institute and on the Biomedical Research Training Program for Underrepresented Minorities at NHLBI, where she received the Director’s Award in 1999. She returned to the Dana-Farber Cancer Institute in July 2002 as Vice President of Patient Safety and Director of the Center for Patient Safety. In 2003, Dr. Bierer moved to the Brigham and Women’s Hospital to assume her current position. In addition, in 2006, Dr. Bierer established the Center for Faculty Development and Diversity at the Brigham and Women’s Hospital and now serves as its first director.
Dr. Bierer’s laboratory research interests include mechanisms of T cell activation and of immunosuppression, interests that complement her clinical commitment to hematology. In addition to her academic responsibilities, Dr. Bierer was elected to the Board of Directors of the Association for Accreditation of Human Research Protection Programs (AAHRPP), serving as its President from 2003-2007, and was on the Board of Directors of the Federation of American Societies for Experimental Biology (FASEB). She was a member of the Medical and Scientific Advisory Board and, later, the Board of Directors of ViaCell, Inc. She is on the editorial boards of a number of journals including Current Protocols of Immunology. She is currently a member of the AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Clinical Research, on the National Academies of Sciences Committee on Science, Technology and the Law, and on the Secretary’s Advisory Committee for Human Research Protections for which she serves as chair.
Elizabeth H. Blackburn (NAS/IOM) is a leader in the area of telomere and telomerase research. She discovered the molecular nature of telomeres – the ends of eukaryotic chromosomes that serve as protective caps essential for preserving the genetic information – and she discovered the ribonucleoprotein enzyme, telomerase. Blackburn and her research team at the University of California, San Francisco are working with various cells including human cells, with the goal of understanding telomerase and telomere biology.
Blackburn earned her B.Sc. (1970) and M.Sc. (1972) degrees from the University of Melbourne in Australia, and her Ph.D. (1975) from the University of Cambridge in England. She did her postdoctoral work in Molecular and Cellular Biology from 1975 to 1977 at Yale.
In 1978, Blackburn joined the faculty at the University of California, Berkeley in the Department of Molecular Biology. In 1990, she joined the Department of Microbiology and Immunology at the University of California, San Francisco, where she served as department chair from 1993 to 1999. Blackburn is currently a faculty member in the Department of Biochemistry and Biophysics at UCSF. She is also a Non-Resident Fellow at the Salk Institute.
Throughout her career, Blackburn has been honored by her peers as the recipient of many prestigious awards. These include the Eli Lilly Research Award for Microbiology and Immunology (1988), the National Academy of Sciences Award in Molecular Biology (1990), and an Honorary Doctorate of Science from Yale University (1991). She was a Harvey Society Lecturer at the Harvey Society in New York (1990), and the recipient of the UCSF Women’s Faculty Association Award (1995). Most recently, she was awarded the Australia Prize (1998), named California Scientist of the Year in 1999, and awarded the Harvey Prize (1999), the Keio Prize (1999), American Association for Cancer Research-G.H.A. Clowes Memorial Award (2000), American Cancer Society Medal of Honor (2000), AACR-Pezcoller Foundation International Award for Cancer Research (2001), General Motors Cancer Research Foundation Alfred P. Sloan Award (2001), E.B. Wilson Award of the American Society for Cell Biology (2001), 26th Annual Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research (2003), The Dr. A.H. Heineken Prize for Medicine (2004), The Kirk A. Landon-AACR prize for Basic Cancer Research (2005) and The Albert Lasker Medical Research Award in Basic Medical Research (2006).
Professor Blackburn was elected President of the American Society for Cell Biology in 1998. She is an elected Fellow of the American Academy of Arts and Sciences (1991), the Royal Society of London (1992), the American Academy of Microbiology (1993), and the American Association for the Advancement of Science (2000). She was elected Foreign Associate of the National Academy of Sciences in 1993, and was elected as a Member of the Institute of Medicine in 2000. In 2007 she was named one of Time Magazine’s 100 Most Influential People.
John Burris became president of the Burroughs Wellcome Fund in July 2008. He is the former president of Beloit College. Prior to his appointment at Beloit in 2000, Dr. Burris served for eight years as director and CEO of the Marine Biological Laboratory (MBL) in Woods Hole, Mass. From 1984 to 1992 he was at the National Research Council where he served as the executive director of the Commission on Life Sciences. A native of Wisconsin, he received an A.B. in biology from Harvard University in 1971, attended the University of Wisconsin-Madison in an M.D.-Ph.D. program, and received a Ph.D. in marine biology from the Scripps Institution of Oceanography at the University of California-San Diego in 1976. A professor of biology at the Pennsylvania State University from 1976 to 1985, he held an adjunct appointment there until coming to Beloit. His research interests were in the areas of marine and terrestrial plant physiology and ecology. He has served as president of the American Institute of Biological Sciences and is or has been a member of a number of distinguished scientific boards and advisory committees including the Grass Foundation, the Stazione Zoologica “Anton Dohrn” in Naples, Italy, the American Association for the Advancement of Science, and the Radiation Effects Research Foundation in Hiroshima, Japan. He has also served as a consultant to the National Conference of Catholic Bishops' Committee on Science and Human Values.
Claude Canizares (NAS) is Vice President and the Bruno Rossi Professor of Physics at the Massachusetts Institution of Technology. He has responsibility for MIT’s major international partnerships and oversees the MIT Lincoln Laboratory.
Professor Canizares earned his BA, MA and Ph.D. in physics from Harvard University. He came to MIT as a postdoctoral fellow in 1971 and joined the faculty in 1974. He has served as Director of the Center for Space Research (1990-2001), Associate Provost (2001-2006), and most recently as Vice President for Research & Associate Provost (2006-2013). Professor Canizares is a principal investigator on NASA's Chandra X-ray Observatory. He has also worked on several other space astronomy missions and is author or co-author of more than 230 scientific papers.
Professor Canizares’ service outside MIT includes the Department of Commerce’s National Advisory Council on Innovation and Entrepreneurship and the Emerging Technology and Research Advisory Committee and the National Research Council’s (NRC) Committee on Science, Technology and the Law. He served as chair of the NRC’s Space Studies Board and was a member of the NASA Advisory Council and the Air Force Scientific Advisory Board, among others. He is also a member of the L-3 Communications, Inc. Board of Directors. Professor Canizares is a member of the National Academy of Sciences and the International Academy of Astronautics and is a fellow of the American Academy of Arts & Sciences, the American Physical Society, and the American Association for the Advancement of Science. He has also received several awards including decoration for Meritorious Civilian Service to the United States Air Force, and two NASA Public Service Medals.
Arturo Casadevall is the Leo and Julia Forchheimer Professor of Microbiology & Immunology and Chair of the Department of Microbiology and Immunology at the Albert Einstein College of Medicine. He is also a Professor in the Department of Medicine. He received his B.A. from Queens College, CUNY, and M.S., M.D. and Ph.D. degrees from New York University. The laboratory has a multidisciplinary research program spanning several areas of basic immunology and microbiology to address these general questions, which has resulted over 460 publications. His laboratory studies are focused on two microbes: the fungus Cryptococcus neoformans, a ubiquitous environmental microbe that is a frequent cause of disease in immunocompromised individuals and Bacillus anthracis, which a major agent of biological warfare. He is a fellow of the American Academy of Microbiology and was elected to the American Society for Clinical Investigation, to the American Association of Physicians and as a fellow of the AAAS. Dr. Casadevall has served on numerous advisory committees to the NIH including study sections, strategic planning for the NIAID and the blue ribbon panel on response to bioterrorism. He currently co-chairs the Board of Scientific Counselors for the NIAID and is a member of the National Science Advisory Board for Biosecurity (NSABB). He is the founding editor of the first ASM general journal, mBio and serves on the editorial boards of several journals, and has been the recipient of numerous awards, most recently the Solomon A. Berson Medical Alumni Achievement Award in Basic Science-NYU School of Medicine 2005, IDSA Kass Lecturer in 2008 and the ASM William Hinton Award for mentoring scientists from underrepresented groups.
Joe S. Cecil, Ph.D. (Psychology), Northwestern University; J.D., Northwestern University, is a Project Director in the Division of Research at the Federal Judicial Center. Currently he is directing the Center’s Program on Scientific and Technical Evidence. As part of this program he is responsible for judicial education and training in the area of scientific and technical evidence and served as principal editor of the first two editions of the center’s Reference Manual on Scientific Evidence which is the primary source book on evidence for federal judges. He has also published several articles on the use of court-appointed experts. He is currently directing a research project that examines the difficulties that arise with expert testimony in federal courts, with an emphasis on clinical medical testimony and forensic science evidence. Other areas of research interest include federal civil and appellate procedure, jury competence in complex civil litigation, and assessment of rule of law in emerging democracies. Dr. Cecil serves on the editorial boards of social science and legal journals. He previously served on the National Academies’ Panel on Confidentiality and Data Access and the Committee on Identifying the Needs of the Forensic Sciences Community. He was also a member the Committee on Science, Technology, and Law's subcommittee on Access to Research Data: Balancing Risks and Opportunities.
Rochelle C. Dreyfuss is the Pauline Newman Professor of Law at New York University School of Law and Co-director of the Engelberg Center on Innovation Law and Policy at NYU. Her research interests include international and domestic intellectual property law as well as civil procedure. She holds B.A. and M.S. degrees in Chemistry and was a research chemist before entering Columbia University School of Law, where she served as Articles and Book Review Editor of the Law Review. She was a law clerk to Chief Judge Wilfred Feinberg of the U.S. Court of Appeals for the Second Circuit and to Chief Justice Warren E. Burger of the U.S. Supreme Court. She is a member of the American Law Institute and was a co-Reporter for its Project on Intellectual Property: Principles Governing Jurisdiction, Choice of Law, and Judgments in Transnational Disputes. She was a consultant to the Federal Courts Study Committee, to the Presidential Commission on Catastrophic Nuclear Accidents, and to the Federal Trade Commission and served on the Secretary of Health and Human Services’ Advisory Committee on Genetics Health and Society [SACGHS]. She is a past chair of the Intellectual Property Committee of the American Association of Law Schools. She was also a member of the National Academies Committee on Intellectual Property in Genomic and Protein Research and Innovation as well as the Committee on Intellectual Property Rights in the Knowledge-Based Economy. She is presently serving on the Academies’ Committee on Science, Technology, and Law and on International Law Association’s Committee on Intellectual Property and Private International Law. Her most recent book is A Neofederalist Vision of Trips: The Resilience of the International Intellectual Property Regime (with Graeme B. Dinwoodie).
Harry T. Edwards was appointed to the U.S. Court of Appeals in February 1980, served as Chief Judge from September 15, 1994, until July 15, 2001, and took senior status on November 3, 2005. He graduated from Cornell University in 1962 and the University of Michigan Law School in 1965. Judge Edwards went into private practice with Seyfarth, Shaw, Fairweather & Geraldson in Chicago from 1965 to 1970. He then moved to the academy and was a tenured member of the faculties at the University of Michigan Law School, where he taught from 1970 to 1975 and 1977 to 1980, and at Harvard Law School, where he taught from 1975 to 1977. He also taught at the Harvard Institute for Educational Management between 1976 and 1982. He served as a member and then Chairman of the Board of Directors of AMTRAK from 1978 to 1980, and also served as a neutral labor arbitrator under a number of major collective bargaining agreements during the 1970s. In 2006, he was appointed the Co-Chair of the Committee on Identifying the Needs of the Forensic Science Community established by the National Academy of Sciences. Judge Edwards has co-authored five books and published scores of law review articles on federal courts, legal education, professionalism, judicial administration, labor law, equal opportunity, and higher education law. His most recent book, Edwards, Elliott, & Levy, Federal Standards of Review, was published by Thomson/Reuters in 2013. Since joining the court, he has taught law at Harvard, Michigan, Duke, Pennsylvania, and Georgetown. He is presently a Professor of Law at the New York University School of Law, where he has taught since 1990.
Drew Endy runs the world's first "fabless" genetic engineering lab in the new Bioengineering program at Stanford University and previously helped start the Biological Engineering major at the Massachusetts Institute of Technology. His Stanford research team develops genetically encoded computers and redesigns genomes. Dr. Endy co-founded the BioBricks Foundation as a public-benefit charity supporting free-to-use standards and technology that enable the engineering of biology. He co-organized the International Genetically Engineered Machines (iGEM) competition and the BIOFAB International Open Facility Advancing Biotechnology (BIOFAB). He is a new voting member of the U.S. National Science Advisory Board for Biosecurity (NSABB). He chaired the 2003 Synthetic Biology Study as a member of DARPA ISAT, served as an ad hoc member of the U.S. NIH Recombinant DNA Advisory Committee, and co-authored the 2007 "Synthetic Genomics: Options for Governance" report with colleagues from the Center for Strategic & International Studies and the J. Craig Venter Institute. Esquire named Endy one of the 75 most influential people of the 21st century. He lives in Menlo Park, CA with his wife and Stanford Bioengineering colleague Professor Christina Smolke.
Marcus Feldman, Ph.D.,is Burnet C. and Mildred Finley Wohlford Professor of Biology at Stanford University and External Professor the Santa Fe Institute. Dr. Feldman’s specific areas of research include the evolution of complex genetic systems that can undergo both natural selection and recombination, the evolution of modern humans using models for the dynamics of molecular polymorphisms, especially DNA variants, and the evolution of learning as one interface between modern methods in artificial intelligence and models of biological processes, including communication. He is the author of more than 440 scientific papers and nine books on evolution, ecology, mathematical biology, and Chinese demography, adding significantly to the greater database over the years.
In 2003, Dr. Feldman’s work received the “Paper of the Year” award for biomedical science from The Lancet
. Dr. Feldman is now working on three books—on gene-culture coevolutionary theory, niche construction in evolutionary biology, and the sex-ratio issue in China—and also serves as academic director of Bridging the Rift, a project to develop collaborations between Israeli and Jordanian scientists. In addition to his teaching, research, writing, and directing, he is managing editor of Theoretical Population Biology
and associate editor of Genetics
, Human Genetics
, Annals of Human Genetics
, Annals of Human Biology
. He is a former editor of The American Naturalist
. Dr. Feldman is a member of the The American Society of Human Genetics and a Fellow of the American Academy of Arts & Sciences and of the California Academy of Sciences. The Hebrew University of Jerusalem and Tel Aviv University have awarded him honorary doctorates of philosophy, and Beijing Normal University and Xi’an Jiaotong University have each appointed him honorary professor.
Jeremy D. Fogel is a federal judge for the United States District Court for the Northern District of California. He became Director of The Federal Judicial Center (FJC) on October 3, 2011.
Born in San Francisco, Judge Fogel received a B.A. (with Great Distinction) in religious studies from Stanford University in 1971. He received a J.D. cum laude from Harvard Law School in 1974. He was in private practice in San Jose, California from 1974 to 1978 and was Founder and Directing Attorney of the Mental Health Advocacy Project, Santa Clara County Bar Association Law Foundation.
Fogel served as a judge on the Santa Clara County Municipal Court from 1981 to 1986. He was appointed as a judge at the Superior Court of Santa Clara County in 1986 and remained there until 1998. Fogel was Presiding Judge, Santa Clara County Municipal Court, from 1984-85; Supervising Judge, Family Law Division, Santa Clara Superior Court, from 1987-88 and in 1995; Supervising Judge, Probate/Mental Health Division, 1991; and Civil Team Leader and Law and Motion Judge, Santa Clara Superior Court from 1992-94 and from 1996-98. In 1998, he was appointed to the United States District Court for the Northern District of California
Judge Fogel was a member of the executive board of the California Judges Association from 1988-91; Vice-President, 1990-91; Chair, Judicial Ethics Committee, 1987-88; Chair, Judicial Discipline Advisory Panel (confidential counseling service for judges facing discipline), 1992-98. He was Chair, Planning Committee, California Continuing Judicial Studies Program from 1995-97. Fogel was a faculty member of the California Continuing Judicial Studies Program and California Judicial College (alternative dispute resolution, psychology, ethics, family law, sexual harassment awareness and prevention, domestic violence, and judicial excellence) from 1987-2009. He was mediation trainer and member, Advisory Committee on ADR Education, Federal Judicial Center, 2002-2009 and faculty, FJC Advanced Patent Program from 2005-present. He has been a member of international legal exchange delegations to various countries in the Middle East, Eastern Europe, Latin America, and East and South Asia (alternative dispute resolution, case management, intellectual property rights and judicial ethics) from 1999-present. Judge Fogel is a frequent lecturer on ethics, discipline and professional conduct for both Bench and Bar. He has been Lecturer, Stanford University Law School (psychology of litigation) from 2003-present (on leave while at FJC).
Judge Fogel is the recipient of the President’s Award for Outstanding Service to the California Judiciary, California Judges Association, 1997; the Judge of the Year Award, Santa Clara County Trial Lawyers Association, 1997, 2005 and 2011; and of the “LACY Honors” Award, Legal Advocates for Children and Youth, Santa Clara County Bar Association Law Foundation, 1997. He is the recipient of the Special Award for Exemplifying Highest Standards of Professionalism in the Judiciary, Santa Clara County Bar Association, 2002. He was named Justice of the Year, San Francisco Trial Lawyers Association and one of California’s 100 most influential lawyers by Daily Journal Corporation in 2007.
Alice P. Gast (NAE) became Lehigh University's 13th president on August 1, 2006. Previously she was the Robert T. Haslam Professor of Chemical Engineering and the Vice President for Research and Associate Provost at Massachusetts Institute of Technology. Prior to moving to MIT in 2001, she spent 16 years as a professor of chemical engineering at Stanford University and at the Stanford Synchrotron Radiation Laboratory. In her research she studies surface and interfacial phenomena, in particular the behavior of complex fluids. Some of her areas of research include colloidal aggregation and ordering, protein lipid interactions and enzyme reactions at surfaces. In 1997 Gast co-authored the sixth edition of “Physical Chemistry of Surfaces” with Arthur Adamson. Professor Gast received her BS in Chemical Engineering from the University of Southern California. After earning her Ph.D. in chemical engineering from Princeton University, Gast spent a postdoctoral year on a NATO fellowship at the École Supérieure de Physique et de Chimie Industrielles in Paris. She returned there for a sabbatical as a Guggenheim Fellow. She was a 1999 Alexander von Humboldt Fellow at the Technical University in Garching, Germany. She received the National Academy of Sciences Award for Initiative in Research, and the Colburn Award of the American Institute of Chemical Engineers. She was elected to the National Academy of Engineering in 2001 and to the American Academy of Arts and Sciences in 2002.
Professor Gast has served on numerous advisory committees and boards, including the Board of the American Association for the Advancement of Science (AAAS) and the National Space Biomedical Research Institute Board of Directors. She is a member of the American Chemical Society, the American Institute of Chemical Engineers, the American Physical Society.
Benjamin W. Heineman, Jr. was GE’s Senior Vice President-General Counsel for GE from 1987-2003, and then Senior Vice President for Law and Public Affairs from 2004 until his retirement at the end of 2005. He is currently Distinguished Senior Fellow at Harvard Law School’s Program on the Legal Profession, Senior Fellow at Harvard Law School’s Program on Corporate Governance, Senior Fellow at the Belfer Center for Science and International Affairs at Harvard’s Kennedy School of Government and Lecturer in Law at Yale Law School. A Rhodes Scholar, editor-in-chief of the Yale Law Journal and law clerk to Supreme Court Justice Potter Stewart, Mr. Heineman was assistant secretary for policy at the Department of Health, Education and Welfare and practiced constitutional law prior to his service at GE. His book, High Performance with High Integrity, was published in June, 2008 by the Harvard Business Press. He writes and lectures frequently on business, law, public policy and international affairs. He is also the author of books on British race relations and the American presidency.
He is a member of the American Philosophical Society, a fellow of the American Academy of Arts and Sciences, and recipient of the American Lawyer’s Lifetime Achievement Award and the Lifetime Achievement Award of Board Member Magazine. He was named one of America’s 100 most influential lawyers by the National Law Journal, was named one of the 100 most influential individuals on business ethics by Ethisphere Magazine and was named on of the 100 most influential people in corporate governance by the National Association of Corporate Directors. He serves on the boards of Memorial Sloan Kettering Cancer Center (chair of patient care committee), the Center for Strategic and International Studies (chair of program committee), Transparency International-USA (chair of program committee) and the Committee for Economic Development (chair of the corporate governance committee). He is a member of the board of trustees of Central European University. He is currently on an international panel advising the President of the World Bank on governance and anti-corruption.
He is a graduate of Harvard College (BA – high honors in history), Oxford University (B.Litt) and Yale Law School (JD).
D. Brock Hornby was born in Canada, obtained his B.A. from the University of Western Ontario, and graduated from Harvard Law School where he was Supreme Court Note and Developments Editor of The Harvard Law Review. He clerked for U.S. Fifth Circuit Judge John Minor Wisdom, taught at the University of Virginia Law School (he became a U.S. citizen during that period), practiced with Perkins, Thompson, Hinckley & Keddy in Portland, Maine, served as a United States Magistrate Judge, then as a Justice of the Maine Supreme Judicial Court and became a United States District Judge in 1990. He is a member of the Council of The American Law Institute. He is a fellow of the American and Maine Bar Foundations. He is a member of the National Academies Standing Committee on Science, Technology and the Law. He has served on both the United States Judicial Conference and its Executive Committee. Previously, the Chief Justice appointed him chair of The Federal Judicial Center’s Committee on District Judge Education, chair of the United States Judicial Conference Committee on Court Administration and Case Management, member of the Judicial Conduct and Disability Act Study Committee (the Breyer Committee) to study the system of judicial discipline for federal judges, and chair of the Judicial Conference Committee on the Judicial Branch. In 2009, Judge Hornby received the 27th Annual Edward J. Devitt Distinguished Service to Justice Award. Judge Hornby has presided over major multidistrict litigation (MDL), antitrust, and data theft class action lawsuits. He has been a lecturer or consultant on United States judicial topics to judges in Argentina, Canada, China, the Czech Republic, England, Moldova and Thailand. Apart from his judicial opinions, he has written on a variety of legal and judicial topics.
Alan B. Morrison, LL.B., Harvard Law School, spent most of his professional career at the Public Citizen Litigation Group in Washington, D.C., which he founded with Ralph Nader in 1972. He is currently the Associate Dean for Public Interest and Public Service at the George Washington University School of Law. Mr. Morrison was Special Counsel to the Attorney General for the District of Columbia from September 2007 to January 2008. Before becoming Special Counsel to the Attorney General, he spent three years as a Senior Lecturer at Stanford Law School where he has taught courses in the fields of litigation, administrative law and legal ethics. He has also taught at the law schools at Harvard, NYU and the University of Hawaii and is a member of the American Law Institute. Prior to his work at Public Citizen he was an associate in a law firm and an Assistant U.S. Attorney in New York City. Mr. Morrison was a commissioned officer in the U.S. Navy after he graduated from Yale College. In 1999-2000 he was President of the American Academy of Appellate Lawyers. Mr. Morrison has served two previous terms on the National Academies Science, Technology, and Law Panel, and was a member of its Subcommittee on Ensuring the Quality of Information Disseminated by the Federal Government.
Cherry A. Murray (NAS/NAE) is Dean of Harvard University’s School of Engineering and Applied Sciences (SEAS); John A. and Elizabeth S. Armstrong Professor of Engineering and Applied Sciences; and Professor of Physics.
Previously, Murray served as principal associate director for science and technology at Lawrence Livermore National Laboratory and was president of the American Physical Society (APS).
Before joining Lawrence Livermore in 2004, Murray was Senior Vice President of Physical Sciences and Wireless Research and had a long and distinguished career at the famed Bell Laboratories.
Murray was elected to the National Academy of Sciences in 1999, to the American Academy of Arts and Sciences in 2001, and to the National Academy of Engineering in 2002. She has served on more than 80 national and international scientific advisory committees, governing boards and National Research Council panels and as a member of the National Commission on the BP Deepwater Horizon Oil Spill and Offshore Drilling. She is currently chair of the National Research Council Division of Engineering and Physical Science.
A celebrated experimentalist, Murray is known for her scientific accomplishments in condensed matter and surface physics.
She received her B.S. in 1973 and her Ph.D. in physics in 1978 from the Massachusetts Institute of Technology. She has published more than 70 papers in peer-reviewed journals and holds two patents in near-field optical data storage and optical display technology.
Roberta B. Ness (IOM), M.D., M.P.H., a recognized expert in women’s health research, became dean of The University of Texas School of Public Health November 1, 2008. She is the School’s fourth dean since it was established in 1969. Dr. Ness also holds the M. David Low Chair in Public Health, is a professor in the Division of Epidemiology and Disease Control, and Vice President for Innovation at The University of Texas Health Science Center at Houston. She is a member of the Institute of Medicine of the National Academies of Science, a fellow of the American College of Physicians and past-President of the American College of Epidemiology. She is President-Elect of the American Epidemiological Society.
Dr. Ness received her M.D. from Cornell University and her M.P.H. from Columbia University. She has been at the forefront of women’s health research, being one of the first to propose the research paradigm now termed “gender based biology” in her book entitled, Health and Disease among Women (Oxford U Press, 1999). In her most recent book, Innovation Generation (Oxford U Press, 2012), which is based on the highly successful program she developed at the UT School of Public Health, she provides the tools needed to think "outside the box." This book and the course provide proven techniques to expand the ability to generate original ideas, which will help scientists develop new strategies to prevent many common chronic diseases.
Dr. Ness is a frequent advisor to the National Institutes for Health, the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, and the Department of Defense. She has taken part in several Institute of Medicine, National Academies’ reports.
Dr. Ness is past-President of the American College of Epidemiology and has served as a member of its board of directors since 2004. Recently, she became the founding chair of the Joint Policy Committee of the Societies of Epidemiology – the first organization to coordinate joint policy actions among 14 epidemiology societies. Dr. Ness is an Associate Editor of the American Journal of Epidemiology, and on the editorial boards of Annals of Epidemiology, and WHO STD Bulletin. She is an elected member of the prestigious American Society for Clinical Investigation, Delta Omega Honorary, and the American Epidemiologic Society.
Dr. Ness was formerly chair of the Department of Epidemiology at the University of Pittsburgh Graduate School of Public Health where she was a professor of epidemiology, medicine, and obstetrics & gynecology. She also served as director of the Epidemiology of Women’s Health Program in the Department of Epidemiology. Dr. Ness was on the faculty at the University of Pittsburgh beginning in 1993 and served as interim dean from 2005-2006. Prior to 1993 she was on the faculty at the University of Pennsylvania.
Harriet Rabb was at Columbia Law School as a clinical professor, head of the clinical program and a member of the faculty during the course of her affiliation of more than two decades there. In 1991, she was named the first George M. Jaffin Professor of Law and Social Responsibility and, in 1992, added the title of vice dean of the law faculty. In 1998, she was the recipient of the Law School’s Lawrence A. Wien Prize for Social Responsibility.
In 1993, Ms. Rabb was confirmed by the United States Senate to serve as general counsel for the U.S. Department of Health and Human Services under Secretary Donna Shalala. As chief legal officer of the Department, Ms. Rabb was responsible for legal matters involving, among other agencies, the National Institutes of Health, the Centers for Disease Control, the Food and Drug Administration, the Health Care Financing Administration and the Administration for Children and Families. Ms. Rabb led the Department’s legal efforts on health policy issues, including human stem cell research, pandemic influenza, tobacco, assisted reproductive technology, tissue and organ allocation, fetal tissue and human embryo research, informed consent and various aspects of vaccines.
In 2001, Ms. Rabb was named to her current position as vice president and general counsel to The Rockefeller University.
David A. Relman, M.D., is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine, and of Microbiology and Immunology at Stanford University, and Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. He is also Co-Director of the Center for International Security and Cooperation and Senior Fellow at the Freeman Spogli Institute for International Studies at Stanford University.
Dr. Relman’s primary research focus is the human indigenous microbiota (microbiome), and in particular, the nature and mechanisms of variation in patterns of microbial diversity and function within the human body, and the basis of microbial community resilience. His work was some of the first to employ modern molecular methods in the study of the microbiome, and provided the first in-depth sequence-based analyses of microbial community structure in humans. During the past few decades, his research has also included pathogen discovery and the development of new strategies for identifying previously-unrecognized microbial agents of disease. He has served as an advisor to a number of agencies and departments within the U.S. Government on matters pertaining to host-microbe interactions, emerging infectious diseases, and biosecurity. He co-chaired a widely-cited 2006 study by the National Academies of Sciences (NAS) on “Globalization, Biosecurity, and the Future of the Life Sciences”, and served as vice-chair of a 2011 National Academies study of the science underlying the FBI investigation of the 2001 anthrax mailings. He currently serves as a member of the National Science Advisory Board for Biosecurity, a member of the Science, Technology & Engineering Advisory Panel for Lawrence Livermore National Laboratory (2012-), as Chair of the Forum on Microbial Threats at the Institute of Medicine (NAS) (2007-), and as immediate past-President of the Infectious Diseases Society of America.
Dr. Relman received an S.B. (Biology) from MIT (1977), M.D. (magna cum laude) from Harvard Medical School (1982), completed his clinical training in internal medicine and infectious diseases at Massachusetts General Hospital, served as a postdoctoral fellow in microbiology at Stanford University, and joined the faculty at Stanford in 1994. He received an NIH Director’s Pioneer Award in 2006, was elected a Fellow of the American Academy of Microbiology in 2003 and the American Association for Advancement of Science in 2010, and was elected a Member of the Institute of Medicine in 2011.
Richard L. Revesz is Lawrence King Professor of Law, Dean Emeritus, and Director, Institute for Policy Integrity at New York University School of Law. He is a leading scholar in several areas of environmental law and policy, including the allocation of authority between the federal government and the states, the use of cost-benefit analysis, and the design of liability rules. In 2008, he published Retaking Rationality: How Cost-Benefit Analysis Can Better Protect the Environment and Our Health. Dean Revesz is also the faculty director of NYU’s Institute for Policy Integrity, a non-partisan think-tank that advocates for an unbiased approach to cost-benefit analysis. He is a member of the Administrative Conference of the U.S., has served on the National Research Council (NRC)'s Committee on Health, Environmental, and Other External Costs and Benefits of Energy Production and Consumption, and on the Science Advisory Board of the U.S. Environmental Protection Agency. He is a Trustee of the American Museum of Natural History, a Fellow of the American Academy of Arts and Sciences, and a member of the Council on Foreign Relations and of the American Law Institute.
David S. Tatel, B.A., University of Michigan (1963); J.D., University of Chicago Law School (1966), is a judge on the United States Court of Appeals for the District of Columbia Circuit. Before this appointment by President Clinton in 1994, Tatel was for fifteen years partner and head of the education group at Hogan & Hartson in Washington, D.C. From 1977 to 1979 he was director of the Office for Civil Rights in the U.S. Department of Health, Education and Welfare under President Carter. Judge Tatel was a member of the Board of Directors for the Spencer Foundation, which he chaired from 1990 to 1997, and he is currently a member of the Board of Directors for the Carnegie Foundation for the Advancement of Teaching, which he chaired from 2006 to 2009.
CSTL STAFF BIOGRAPHIES
Anne-Marie Mazza, Director. B.A., Economics; M.A., History and Public Policy; Ph.D., Public Policy, The George Washington University. Dr. Mazza joined the National Academies in 1995. She has served as Senior Program Officer with both the Committee on Science, Engineering and Public Policy and the Government-University-Industry Research Roundtable. In 1999 she was named the first director of the Science, Technology, and Law Program. Between October 1999 and October 2000, she divided her time between the STL Program and the White House Office of Science and Technology Policy, where she served as a Senior Policy Analyst.
Steven Kendall, Program Officer. B.A., Art History, Kent State University; M.A. Victorian Art & Architecture, University of London, Ph.D., Art History, University of California, Santa Barbara. Dr. Kendall has contributed to numerous Academy reports including Positioning Synthetic Biology to Meet the Challenges of the 21st Century (2013); Perspectives on Research with H5N1 Avian Influenza: Scientific Inquiry, Communication, Controversy (2012); Review of the Scientific Approaches Used During the FBI’s Investigation of the 2001 Anthrax Mailings (2011), Managing University Intellectual Property in the Public Interest (2010); and Strengthening Forensic Science in the United States: A Path Forward (2009). Prior to joining The National Academies in 2007, he worked at the Smithsonian American Art Museum and The Huntington in San Marino, California.